CNS Drug Mechanisms of Action Flashcards
Ethosuximide
blocks thalamic T-type Ca2+ channels
Benzodiazepines
Facilitate GABA(A) action by increased frequency of Cl- channel opening
Barbiturates
Facilitate GABA(a) action by increasing duration of Cl- channel opening, thus decreasing neuronal firing
Non-benzodiazepine hypnotics
Act via BZ1 subtype of the GABA receptor- reversed by flumazenil
Suvorexant
Orexin (hypocretin) receptor antagonist
Ramelteon
Melatonin receptor agonist, binds MT1 and MT2 in suprachiasmatic nucleus
Triptans
5-HT(1B/1D) agonists; inhibit trigeminal nerve activation; prevent vasoactive peptide release; induce vasoconstriction
Bromocriptine
Dopamine agonist
Amantadine
Increases DA release and decreases DA reuptake
Carbidopa
Blocks peripheral conversion of L-DOPA to DA by inhibiting DOPA decarboxylase
Entacapone
COMT inhibitor
Tolcapone
COMT inhibitor
Selegiline
MAO-B inhibitor
Benztropine
Antimuscarinic adjunct to improve tremor and rigidity
Trihexyphenidyl
Antimuscarinic adjunct to improve tremor and rigidity
Rasagiline
MAO-B inhibitor
Tetrabenazine
Inhibit vesicular monoamine transporter (VMAT)–> decreases DA vesicular packaging and release
Reserpine
Inhibit vesicular monoamine transporter (VMAT)–> decreases DA vesicular packaging and release
Riluzole
Decreases glutamate excitotoxicity; ALS treatment
Memantine
NMDA receptor antagonist
Tacrine
AChE inhibitor
Baclofen
Activates GABA(A) receptors at level of spinal cord, inducing skeletal muscle relaxation
Cyclobenzaprine
Centrally acting skeletal muscle relaxant
Pentazocine
Kappa-opioid receptor agonist and mu-opioid receptor weak/ partial agonist; analgesia